United Therapeutics

3D Printing Financials: 3D Systems Undertakes Restructuring Amid Mixed Q3 Earnings

Just as 3D Systems (NYSE: DDD) had anticipated in its preliminary results last October, the company has unveiled its financial performance for the third quarter ending on September 30, 2023….


3D Systems Spins off Bioprinting Startup Systemic Bio

After venturing deeply into the bioprinting space, 3D Systems (NYSE: DDD) is shifting gears by spinning out its assets in this sector into a new, wholly owned company: Systemic Bio….


3D Printed Human Lung Scaffold Showcased by 3D Systems and United Therapeutics

Ever since 3D Systems (NYSE: DDD) partnered with biotech firm United Therapeutics (Nasdaq: UTHR) in 2017, the duo have focused on printing scaffolds for human lungs. The hope is that…

AMS Speaker Spotlight: The Current Uses of Bioprinting

Authors: Taci Pereira, Vice President and General Manager of Bioprinting for 3D Systems, and Yu Shrike Zhang, Assistant Professor at Harvard Medical School, will be participating in Additive Manufacturing Strategies…


3D Systems Pursuing Breakthrough Advances in Bioprinting, Acquires Volumetric

The benefits of regenerative medicine are too great to ignore, which is why many investors and companies are flocking to the biotech sector. One of them is 3D Systems (NYSE:…


3D Printed, Vascularized Lung Models Push 3D Systems into Bioprinting

3D Systems (NYSE:DDD) has announced that it is diving further into the bioprinting space, upon significant progress made by its partner United Therapeutics Corporation (NASDAQ:UTHR) and its subsidiary Lung Biotechnology…

CollPlant & United Therapeutics Expand Collaboration to 3D Print Kidneys

Currently, over 100,000 individuals in the US are on the waiting list for organ transplants. Kidney patients make up the majority of the requests, with over 90,000 people hoping for…